Oakwood Capital Management’s AbbVie ABBV Stock Holding History

Oakwood Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$5.22M	Buy	46,314 +1,302	+3%	+$147K	1.35%	34
2021 Q1	$4.87M	Sell	45,012 -307	-0.7%	-$32.8K	1.44%	32
2020 Q4	$4.86M	Sell	45,319 -199	-0.4%	-$19.1K	1.48%	32
2020 Q3	$3.99M	Sell	45,518 -88	-0.2%	-$8.29K	1.47%	31
2020 Q2	$4.48M	Buy	+45,606	New	+$4.02M	1.86%	23
2019 Q2	–	Sell	-56,320	Closed	-$4.54M	–	51
2019 Q1	$4.54M	Sell	56,320 -1,605	-3%	-$131K	1.9%	27
2018 Q4	$5.34M	Sell	57,925 -85	-0.1%	-$7.47K	2.5%	21
2018 Q3	$5.49M	Buy	58,010 +144	+0.2%	+$13.7K	2.22%	25
2018 Q2	$5.36M	Sell	57,866 -1,670	-3%	-$163K	2.26%	22
2018 Q1	$5.63M	Sell	59,536 -755	-1%	-$82.9K	2.41%	18
2017 Q4	$5.83M	Sell	60,291 -2,174	-3%	-$205K	1.29%	28
2017 Q3	$5.55M	Sell	62,465 -460	-0.7%	-$35K	1.3%	29
2017 Q2	$4.56M	Sell	62,925 -2,720	-4%	-$183K	1.13%	37
2017 Q1	$4.28M	Sell	65,645 -380	-0.6%	-$23.9K	1.07%	40
2016 Q4	$4.13M	Sell	66,025 -31,548	-32%	-$1.93M	1.06%	43
2016 Q3	$6.15M	Sell	97,573 -1,862	-2%	-$121K	1.58%	22
2016 Q2	$6.16M	Sell	99,435 -1,230	-1%	-$74.9K	1.61%	21
2016 Q1	$5.75M	Buy	100,665 +7,160	+8%	+$399K	1.52%	27
2015 Q4	$5.54M	Sell	93,505 -5,370	-5%	-$309K	1.49%	29
2015 Q3	$5.38M	Buy	98,875 +7,202	+8%	+$469K	1.5%	25
2015 Q2	$6.16M	Buy	91,673 +5,165	+6%	+$337K	1.6%	19
2015 Q1	$5.06M	Buy	86,508 +4,888	+6%	+$295K	1.39%	27
2014 Q4	$5.34M	Buy	81,620 +1,854	+2%	+$117K	1.52%	26
2014 Q3	$4.61M	Buy	+79,766	New	+$4.43M	1.34%	32

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Oakwood Capital Management's ABBV Position: Q2 2021 in Review

Oakwood Capital Management increased its AbbVie (ABBV) stake by 2.9% in Q2 2021, buying an estimated $147K and bringing the position to 46,314 shares worth $5.22M. The position accounts for 1.35% of the portfolio, ranked #34.

Oakwood Capital Management first reported a position in ABBV in Q3 2014 and has held it in 24 quarters since. The position peaked at $6.16M in Q2 2015. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Oakwood Capital Management held 46,314 shares of AbbVie worth $5.22M as of Q2 2021.
Oakwood Capital Management bought 1,302 AbbVie shares in Q2 2021, an estimated $147K.
AbbVie made up 1.35% of Oakwood Capital Management's portfolio in Q2 2021, its #34 holding.
Oakwood Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 24 quarters since.
Oakwood Capital Management's AbbVie position peaked at $6.16M in Q2 2015.
2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Oakwood Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.